RPL22P13

Across TCGA pan-cancer cohorts, RPL22P13 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RPL22P13 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher RPL22P13 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL22P13 expression acts as an unfavorable survival marker, although some lineages such as CESC and LUSC show a favorable association.

KICH, ACC, and UVM are the cancer types where RPL22P13 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Tertile	All	0.026	0.904	<.001	99	view →
ACC	DFS	Tertile	IV	0.010	0.383	<.001	84	view →
UVM	DFS	Tertile	III,IV	0.071	0.636	<.001	54	view →
CESC	DFS	Tertile	II,III,IV	0.906	0.635	.004	48	view →
THYM	DFS	Tertile	III,IV	0.317	0.913	<.001	39	view →
MESO	OS	Tertile	II,III,IV	0.253	0.444	.006	36	view →
KIRC	DFS	Tertile	All	0.504	0.669	.010	24	view →
LUAD	OS	Tertile	All	0.687	0.807	.030	21	view →
HNSC	DFS	Tertile	II,III,IV	0.196	0.383	.010	17	view →
LUSC	DFS	Quartile	II,III,IV	0.518	0.329	.016	16	view →
UCEC	OS	Median	All	0.756	0.613	.026	10	view →
SKCM	OS	Tertile	All	0.872	0.747	.020	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RPL22P13–KICH (DFS)

Open the KICH breakdown →